The social climate is always tense at Sophartex. This Monday, February 8, around forty employees of the laboratory on rue de Nuisement, in Vernouillet, observed a walkout at the beginning of the afternoon and announced a strike movement for Tuesday, February 9.
The tension is also due to a disagreement with the union representative
The strikers want to obtain the withdrawal “of an agreement which goes back on the collective agreement of the pharmacy” and of which they contest the legitimacy of the signature: “The agreement was signed by a CGT union representative who was dismissed and did not is not representative of employees “.
They denounce an atmosphere that is difficult to live with on a daily basis.
“The working atmosphere is degraded even for employees who have more than twenty years of home and who are objectively worn and tired. We are under pressure, people who are judged too often on sick leave, are threatened with dismissal”.
Striking employees (empty)
–
–
Some dismissed employees consider themselves “victims of an injustice” and have taken steps to bring the matter to the Prud’homme.
The HRD of the Synerlab group had justified the layoffs
The management, for its part, believes that this tension is due to the change in work habit. Jean-Noël Thiollier, HR Director of the Synerlab group, comments on a new situation for employees and talks about an adaptation period.
“We negotiated an agreement for eight months which entered into force at the beginning of January. It makes the employees go to 3/8 instead of 2/8. It is a change to which they must adapt. But, this additional d hours is accompanied by an increase in wages of 8% to 12% “.
Jean-Noel Thiollier (Group HR Director)
–
The director does not hide that “we need to increase the profitability of this site which is losing 4 million per year”.
Ipsen also a victim of the drop in the consumption of certain drugs and the development of generics
The Covid crisis is not helping. “Like many manufacturers, we are faced with a drop in the consumption of drugs. Everything concerning gastro, for example. It’s good for people, a little less good for laboratories”. Beyond this wit, he emphasizes that the manufacture of other drugs cannot be obtained overnight: authorizations, protocols … are long to obtain and put in place. The drug is not quite a product like any other.
Valerie Beaudoin
– .
